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INTRODUCTION 
What We Talk About When We Talk 
About Health Reform
Lindsay F. Wiley
With appreciation to Raymond Carver,
1 this 
commentary explores the question: what 
do we talk about when we talk about health 
reform? The tile of the symposium published in this 
issue, Next Steps in Health Reform, and ASLME’s 
aspiration to continue the Next Steps conference on a 
biannual basis beg another question: are we going to 
be talking about health reform forever?
When we talk about health, we talk about the United 
States as an outlier. U.S. health care expenditures per 
capita are the highest in the world, exceeding those 
of the second highest spender by more than 30%.2 In 
spite of spending about twice as much on health care 
as other similarly situated countries,3 the U.S. expe-
riences below-average outcomes by most measures.4 
U.S. life expectancy is lower and growing more slowly 
than in other comparable countries.5 Among its eco-
nomic peers, the U.S. has the highest maternal mor-
tality rate — nearly triple the rate of its closest rival — 
and the rate is increasing in the U.S. even as it declines 
in every other wealthy country.6
When we talk about health reform, we talk about 
whether access to health care and healthy living condi-
tions is a right or an individual responsibility. Most other 
countries have made commitments to respect, protect, 
and fulfill the health-related needs of their populations 
through international human rights instruments and 
national constitutional provisions.7 In countries with 
gross domestic product similar to that of the U.S., the 
right to health is secured in part through universal 
health care systems highly dependent on public financ-
ing8 closely integrated with public health systems that 
assure the conditions required for people to be healthy.9 
In the U.S., however, health care remains first and fore-
most an economic good financed through a fragmen-
tary system of public and private coverage subsidized 
to varying degrees. Access to high quality clinical care, 
healthy living conditions, and good health outcomes 
are among the prizes for doing well financially.
If we solve these problems, if we achieve universal 
coverage, strengthen the social safety net, and bring 
U.S. health care costs and outcomes into alignment 
with those of peer nations, will we be done talking 
about health reform? Probably not. Britain contin-
ues to grapple with the impacts of fiscal austerity on 
its National Health Service.10 In a recent op-ed in the 
New York Times, “Why It’s So Hard to Reform Cana-
dian Health Care,” Danielle Martin lamented:
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About This Symposium
This symposium issue is the product of the 2017 Next Steps 
in Health Reform Conference.  American University Wash-
ington College of Law launched the Next Steps in Health 
Reform conference in 2012 with a reprise in 2015. In 2017, 
in partnership with the American Society of Law, Medicine 
and Ethics (ASLME) and with support from our co-sponsors, 
American University School of Public Affairs, American Uni-
versity Kogod Business School, and the University of Toronto 
Institute for Health Policy, Management and Evaluation, we 
expanded the event to a three-day conference bringing 
together speakers and attendees from multiple disciplines, 
from the academy and practice, and from across the U.S. and 
Canada.
In 2018,  ASLME’s Board of Directors voted to continue the 
conference on a biannual basis, alternating with ASLME’s 
other flagship biannual gathering, the Public Health Law 
Conference. Plans for Next Steps in Health Reform 2019 are 
underway. For updates, please visit https://www.wcl.american.
edu/impact/initiatives-programs/health/healthreform.
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More robust dialogue is needed to really tackle… 
important problems [in the Canadian health care 
system] — but the long American shadow chills 
our discussions. Fear of an American-style mar-
ket-based system inhibits a national conversation 
about how to expand the breadth of coverage 
and increase the timeliness of services. Instead 
of talking about how to make our system better, 
we’re talking about how much worse things are in 
the United States.11
Health reform is an ongoing, iterative process,12 in this 
country and in others. There will always be, it seems, 
more steps needed to sustain health reform in the face 
of competing interests and priorities.
This is an incredibly dynamic time for the U.S. 
health care industry. Federal initiatives under the 
Affordable Care Act have reformed risk-based under-
writing, expanded eligibility for publicly financed 
coverage under Medicaid,13 made private insurance 
more accessible via subsidies and direct regulation,14 
and attempted to control costs.15 The market is rapidly 
consolidating, at least partly in response to a funda-
mental shift in how we pay for goods and services that 
make up more than one-fifth of the U.S. economy.16 
Health care providers and payers are taking on new 
responsibility for health outcomes.17
Like previous transitions, implementation of the 
Affordable Care Act has prompted policymakers, legal 
practitioners, judges, health care providers, public 
health officials, researchers, and scholars to rethink 
the lenses through which they view the complex rela-
tionship between law and health and the role of the 
public’s interest in health care. At the same time, 
friends and neighbors across the country are talking 
about our health system, who it serves, who it fails, 
and how we can do better. A recent Washington Post 
article about two West Virginia bus drivers included 
this moment:
When it came to Trump or most national issues, 
they jousted, like cable-news combatants eased 
into armchairs.
But on the issues they could influence, the 
ones that mattered the most in their lives, the 
two were in harmony. Cochran hated the Afford-
able Care Act and Black backed it. Now, their 
bodies failing, both men support universal health 
care.
“I’ll give a little more out of my paycheck for 
everyone to be covered,” Black had said in an 
earlier discussion with Cochran.
“Me too,” Cochran had agreed. “We pay more 
every year to be told no.”18
The political debate over the ACA — in living rooms 
and classrooms, in statehouses19 and on Capitol Hill 
— continues. So far, the backlash against the ACA has 
been surprisingly ineffectual.20 Even as public support 
for universal health care and more radical routes to 
achieve it (including public-option and single-payer 
plans) has grown, attacks on Medicaid (a bedrock of 
the U.S. health system) continue to mount.21
What we really talk about when we talk about 
health reform — whether we acknowledge it openly or 
bury it in the details — is justice. As Dan Beauchamp 
wrote in 1976, “[The dream] that preventable death 
and disability ought to be minimized is a dream of 
social justice.”22 But social justice is not the only game 
in town. Notions of market justice and actuarial fair-
ness also lay claim to moral rectitude. The struggle 
to agree on the next steps in health reform surfaces 
deep anxieties about our mutual interdependence and 
shared vulnerability. Which conditions should trigger 
a community response? Who is part of the commu-
nity? Who should be the givers and takers and what 
should they be expected to give and take? Public dis-
course grappling with these questions has taken on a 
new tone of conciliation and goodwill in the past year. 
Friends and neighbors who disagree about so many 
other things are finding at least one point of agree-
ment: the way things are now is not working.23 As Ed 
Sparer wrote in 1984, “the very struggle to reconstruct 
health care, organized along mutual aid lines which 
stress cooperative and caring relations, helps to pro-
vide a grace…and character to society and to each 
person who struggles for it.”24 With gratitude for the 
many brilliant, committed colleagues I have the privi-
lege of working with in this endeavor, many of whom 
have contributed to this symposium, I am ready to talk 
about health reform for the foreseeable future.
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